Last updated: 2026-09-06 10:09:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
XOMA Royalty Corporation (XOMAO) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at --, with a market capitalization of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from -- to --. This page covers its latest market performance, valuation, price trends and company information.
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- |
XOMA Royalty Corporation (XOMAO) last closed at $-- as of --, -- from the previous close of $--.
During the latest regular trading session, XOMAO traded between $-- and $--, with a volume of -- shares. The closing price was -- and --.
Over the past seven days, XOMA Royalty Corporation (XOMAO) moved from $25,14 to $25,00, representing a decline of 0,56% ($0,14).
The stock traded between $24,92 and $25,14 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 5,84 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates. The Company's drug royalty aggregator business is mainly focused on the acquisition of early to mid-stage clinical assets. Geographically, the company operates in Switzerland, the United States, Asia Pacific, Europe, and other regions.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 14 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of XOMA Royalty Corporation (XOMAO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.